EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS105-29444 
Organism
Homo sapiens 
Tissue/cell
IMR90 
Coordinate
chr16:2040200-2041970 
Target genes
Number: 50             
NameEnsembl ID
IFT140ENSG00000187535
CRAMP1LENSG00000007545
HN1LENSG00000206053
MAPK8IP3ENSG00000138834
LA16cENSG00000261207
NME3ENSG00000103024
MRPS34ENSG00000074071
EME2ENSG00000197774
SPSB3ENSG00000162032
NUBP2ENSG00000095906
RP11ENSG00000261661
FAHD1ENSG00000180185
HAGHENSG00000063854
C16orf73ENSG00000162039
MSRB1ENSG00000198736
RPL3LENSG00000140986
NDUFB10ENSG00000140990
SNORA10ENSG00000206811
SNORA64ENSG00000207405
AC005363.9ENSG00000255513
RPS2ENSG00000140988
SNHG9ENSG00000255198
RNF151ENSG00000179580
TBL3ENSG00000183751
NOXO1ENSG00000196408
GFERENSG00000127554
SYNGR3ENSG00000127561
AC005606.15ENSG00000260107
ZNF598ENSG00000167962
NPWENSG00000183971
SLC9A3R2ENSG00000065054
TSC2ENSG00000103197
NTHL1ENSG00000065057
PKD1ENSG00000008710
RAB26ENSG00000167964
TRAF7ENSG00000131653
CASKIN1ENSG00000167971
MLST8ENSG00000167965
C16orf79ENSG00000182685
PGPENSG00000184207
E4F1ENSG00000167967
DNASE1L2ENSG00000167968
ECI1ENSG00000167969
AC009065.1ENSG00000167970
RNPS1ENSG00000205937
ABCA17PENSG00000238098
ABCA3ENSG00000167972
ATP6V0CENSG00000185883
AMDHD2ENSG00000162066
PDPK1ENSG00000140992
TF binding sites/motifs
Number: 6             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ATF3MA0605.2chr16:2040360-2040372GGTGACGTCACC+6.22
ATF3MA0605.2chr16:2040360-2040372GGTGACGTCACC-6.22
CREB1MA0018.3chr16:2040360-2040372GGTGACGTCACC+7.22
CREB1MA0018.3chr16:2040360-2040372GGTGACGTCACC-7.22
NR2F1MA0017.2chr16:2041214-2041227CAGAGGTCAACGG+6.71
ZNF263MA0528.1chr16:2040449-2040470GCCTCTACCCCTACCTCCTCC-6.27
Number of super-enhancer constituents: 13             
IDCoordinateTissue/cell
SE_68103chr16:2008747-2090503TC32
SE_68104chr16:2008747-2090503TC32
SE_68105chr16:2008747-2090503TC32
SE_68106chr16:2008747-2090503TC32
SE_68107chr16:2008747-2090503TC32
SE_68108chr16:2008747-2090503TC32
SE_68109chr16:2008747-2090503TC32
SE_68110chr16:2008747-2090503TC32
SE_68111chr16:2008747-2090503TC32
SE_68112chr16:2008747-2090503TC32
SE_68113chr16:2008747-2090503TC32
SE_68114chr16:2008747-2090503TC32
SE_68115chr16:2008747-2090503TC32
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr1620403682040400
chr1620411172041468
Enhancer Sequence
GGGTGAGTGG TCCCTGCCCG GGCCCCCGCT CCCGCCCCTG CCTCGCGACC TTCAGGCCCC 60
TACCAGCCCC CTGCCCCCTA CCCCCTGCCC CCTGCTTCTC GCCCCCCGAC CTCACTCACT 120
CTCATCCTCG CCGGCCCCTC CCCCGCCGGC CTCAGGTTGG GGTGACGTCA CCGGGCAGGG 180
CGCGCCCACC TGCGGGCGGA GGAGGGGCCG GCGGCGCCGG AGAGGGACCT TGAGAGGTCA 240
CCGCCGGTCG CCTCTACCCC TACCTCCTCC CCGGGTCTAA TTTCAGTCCC TTTCCGCAGC 300
CCTTACTCCG TTTTTCCTGT TCTCGTGACC TGGAAGCAGG GACGGGGTGG GGACGGAATT 360
CTCCGAGGGG CAGGAGGGGG CTACGGGAAC CGAGAAGCGC CTCCCCTTCC CCCGCACACA 420
CACCCTCGGG TCTCCTTGGC AGGGAGCCTG TCCCCTGGCC CCCAGTTCCA GCTGTGAGTT 480
GAGGGAGGAG AGGCTCTGGG CTGGGAGGGC TTCCTGGCGG CGGTGTGGAA GGCAGGTTTG 540
GGAGCAGCCT AGCCCACTGG GGCGTCCCTG GGAGGGCCCT GCTGCTCCTT CCCTCCGGCA 600
GGGGAGGTGG CAGTTGGGTG CCGAGCTCTG GGTTTTGTCC AGGTGGCAAC CTCTGGGCCA 660
GCCGCACCTC GGCGCCTGTC TTGGAGGAGG GCGGTGCCCA CGGTGGGGCA GGGGCTTTGG 720
CCTCCCCTGC GGAGTGGCTC TGACCAGACC GGGAGGCAGG ACGCTGCGTT TTGGTCCGAG 780
CGCACGTCCC GACTTGTGGC CCACTCTTGG GGACAAGTGC ATGTCCCGGC TTCCCCCTTG 840
GCTCCACTCT CGGAGCTGGA GCGGGAAAGG AGCGAAGGGA TGAGGTTGAG GCTGGAGGTC 900
GTTTCTTGGA AACACAGGGC TGCCCCGTGC AGCGCTGGTT AAAATGACTG CGGTCCCCCT 960
CATGCCTGTC TCCCGGAACT GGTGGGCAGG AGGCATTGAG GTTTGACGGA ACCTCAGAGG 1020
TCAACGGTGT CATCTTTTCA GCCCAAACAC TTACAGGTGA TATTAATAAT CAGTCACGTG 1080
GGGGCTGTCA TCCCTCGGGT ACCCACCACG TGCAGGAAGC TGGGTGGACA TGTCTGTCCC 1140
AGCACTGCAT GAGCTGTGCC CGTCACCCTA TTTGCATGCT AGAAAACAGG CCAGACAGTT 1200
CCCAACCGCG CAGGAAGCAA CAGCTCCGCT GCCTCCATAC CCTCCCTCCC GCCCCGCTCT 1260
GCCTGCTGCA CTCTCACCTC CCCTTCGCCG TTCCGGCTCC AGCCTGGGAA TCGCGGGCCC 1320
AGGTGAAGGC TCCTGTTCCC ACACTCTTGA GTGGGCTCTG AGGGGACTCC ACGGGCCCAC 1380
GCGGTGCAGA GTACCTGGCT TGAATCAACC CCGGCTTTTG TCAGCCATGT GATCCCGGAC 1440
AAGTCACTTC ACCTGTTGGG GTCCCAATGT CCCCCGCATT TATAAAGAGA ATAAGAACAA 1500
TGGCGATCCC ACGGGGACTT TCTGAGGATT TGGTGAGGGG ACGCATGTAA AGTGGCTGTT 1560
TAACACAATG TCTGGGCATA GTAGATGCTC ACTAAACGGC CCGTGTTGTC AATAATTACT 1620
AAATACGCGA GGGTTCGGGA AAGAAAGAGG TGACACCGCC CCCCACCCAG ATACGGGCCT 1680
GGGAACGCAG GGACAGGCCC AGGGGCGTGG GCGCTCGAGG CGGGCTCGCA GAGGTCGGGT 1740
CGCCGCAGGG CCCTGAGCGC CGCGCCGCAC 1770